275 related articles for article (PubMed ID: 34685635)
21. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
Yoshizawa H; Chang AE; Shu SY
Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
[TBL] [Abstract][Full Text] [Related]
22. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
23. Differentiation and Regulation of T
Basu A; Ramamoorthi G; Albert G; Gallen C; Beyer A; Snyder C; Koski G; Disis ML; Czerniecki BJ; Kodumudi K
Front Immunol; 2021; 12():669474. PubMed ID: 34012451
[TBL] [Abstract][Full Text] [Related]
24. Targeting tumor-related immunosuppression for cancer immunotherapy.
Frumento G; Piazza T; Di Carlo E; Ferrini S
Endocr Metab Immune Disord Drug Targets; 2006 Sep; 6(3):233-7. PubMed ID: 17017974
[TBL] [Abstract][Full Text] [Related]
25. Suppression of nitric oxide generated by inflammatory macrophages by calcitonin gene-related peptide in aqueous humor.
Taylor AW; Yee DG; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jul; 39(8):1372-8. PubMed ID: 9660485
[TBL] [Abstract][Full Text] [Related]
26. T-cell programming in pancreatic adenocarcinoma: a review.
Seo YD; Pillarisetty VG
Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
[TBL] [Abstract][Full Text] [Related]
27. Hepatic Stellate Cells Enhance Liver Cancer Progression by Inducing Myeloid-Derived Suppressor Cells through Interleukin-6 Signaling.
Hsieh CC; Hung CH; Chiang M; Tsai YC; He JT
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614930
[TBL] [Abstract][Full Text] [Related]
28. Providence of the CD25
Chakraborty S; Bhattacharjee P; Panda AK; Kajal K; Bose S; Sa G
Immunol Cell Biol; 2018 Nov; 96(10):1035-1048. PubMed ID: 29768737
[TBL] [Abstract][Full Text] [Related]
29. Regulatory T cells and myeloid-derived suppressor cells in the tumor microenvironment undergo Fas-dependent cell death during IL-2/αCD40 therapy.
Weiss JM; Subleski JJ; Back T; Chen X; Watkins SK; Yagita H; Sayers TJ; Murphy WJ; Wiltrout RH
J Immunol; 2014 Jun; 192(12):5821-9. PubMed ID: 24808361
[TBL] [Abstract][Full Text] [Related]
30. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide-producing CD11b(+)Ly-6G(Gr-1)(+)CD31(ER-MP12)(+) cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice.
Angulo I; de las Heras FG; García-Bustos JF; Gargallo D; Muñoz-Fernández MA; Fresno M
Blood; 2000 Jan; 95(1):212-20. PubMed ID: 10607705
[TBL] [Abstract][Full Text] [Related]
32. Trichosanthin inhibits antigen-specific T cell expansion through nitric oxide-mediated apoptosis pathway.
Li F; Mei Y; Wang Y; Chen C; Tu J; Xiao B; Xu L
Cell Immunol; 2005 Mar; 234(1):23-30. PubMed ID: 15967422
[TBL] [Abstract][Full Text] [Related]
33. Recombinant
Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
[TBL] [Abstract][Full Text] [Related]
34. Targeting iNOS to increase efficacy of immunotherapies.
Ekmekcioglu S; Grimm EA; Roszik J
Hum Vaccin Immunother; 2017 May; 13(5):1105-1108. PubMed ID: 28121247
[TBL] [Abstract][Full Text] [Related]
35. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
36. T cell–derived inducible nitric oxide synthase switches off Th17 cell differentiation.
Jianjun Yang ; Zhang R; Lu G; Shen Y; Peng L; Zhu C; Cui M; Wang W; Arnaboldi P; Tang M; Gupta M; Qi CF; Jayaraman P; Zhu H; Jiang B; Chen SH; He JC; Ting AT; Zhou MM; Kuchroo VK; Morse HC; Ozato K; Sikora AG; Xiong H
J Exp Med; 2013 Jul; 210(7):1447-62. PubMed ID: 23797094
[TBL] [Abstract][Full Text] [Related]
37. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide and glucocorticoids synergize in inducing apoptosis of CD4⁺8⁺ thymocytes: implications for 'Death by Neglect' and T-cell function.
Cohen O; Ish-Shalom E; Kfir-Erenfeld S; Herr I; Yefenof E
Int Immunol; 2012 Dec; 24(12):783-91. PubMed ID: 22949567
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
Parker KH; Beury DW; Ostrand-Rosenberg S
Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulatory and Effector Activities of Nitric Oxide and Reactive Nitrogen Species in Cancer.
Fionda C; Abruzzese MP; Santoni A; Cippitelli M
Curr Med Chem; 2016; 23(24):2618-2636. PubMed ID: 27464520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
